Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Rap guanine nucleotide exchange factor (GEF) 4 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.1252 | 0.4247 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0438 | 0.1423 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0106 | 0.0365 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2687 | 0.9234 |
Brugia malayi | hypothetical protein | 0.0043 | 0.1252 | 0.1226 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0582 | 0.0555 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2908 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.2908 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0029 | 0.0099 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.3613 | 0.3595 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0106 | 0.0365 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.2908 | 0.2887 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0218 | 1 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2091 | 0.2068 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.154 | 0.1515 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0029 | 0.0099 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0106 | 0.0365 |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.1392 | 0.1367 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1252 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2091 | 0.2068 |
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.0259 | 0.089 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2908 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1137 | 0.1111 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1137 | 0.3909 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.2908 | 0.2887 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.1252 | 0.4247 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1249 | 0.4237 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.1655 | 0.1631 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.2904 | 0.9986 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.0143 | 0.0115 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2687 | 0.9234 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0021 | 0.0106 | 0.0269 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.0259 | 0.0799 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.2908 | 0.2887 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0438 | 0.1423 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2908 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.1252 | 0.4304 |
Trypanosoma brucei | ISWI complex protein | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2908 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1252 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0029 | 0.0099 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0021 | 0.0106 | 0.0269 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0323 | 0.111 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.1252 | 0.4304 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2091 | 0.2068 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1252 | 0.5 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.0021 | 0.0106 | 0.0269 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.3354 | 0.3335 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2908 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.2908 | 0.2887 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1252 | 0.5 |
Brugia malayi | RNA binding protein | 0.0076 | 0.2908 | 0.2887 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.0259 | 0.0799 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1249 | 0.4237 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0106 | 0.0365 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2091 | 0.2068 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.2908 | 1 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.0021 | 0.0106 | 0.0269 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0029 | 0.0099 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0438 | 0.1508 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0106 | 0.0078 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.2908 | 0.2887 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0323 | 0.0295 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1137 | 0.1111 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.1396 | 0.1372 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7079 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 32.6294 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.